๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Risks associated with the use of intravenous immunoglobulin

โœ Scribed by L.Ross Pierce; Nisha Jain

Book ID
114268224
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
100 KB
Volume
17
Category
Article
ISSN
1532-9496

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Hemolytic anemia associated with intrave
Hemolytic anemia associated with intravenous immunoglobulin
โœ John R. Wilson; Nirmala Bhoopalam; Morris Fisher ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 46 KB ๐Ÿ‘ 2 views

Intravenous immunoglobulin (IVIg) is a useful tool in the treatment of a variety of neuromuscular disorders. Though IVIg therapy is generally safe, hemolytic anemia is a potentially serious complication that is often overlooked, and is currently not listed in product inserts. We analyzed 45 patients

Acute renal failure associated with intr
Acute renal failure associated with intravenous immunoglobulins
โœ Valรฉrie Gras; Michel Andrรฉjak; Guillaume Decocq ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 84 KB ๐Ÿ‘ 2 views

Intravenous immunoglobulins (IVIG) are increasingly used in various clinical situations for which they have been considered to be safe and eective. However, since 1987, some cases of renal toxicity have been reported. Forty-nine cases of acute renal failure have been notiยฎed to the French Regional

Use and abuse of intravenous immunoglobu
Use and abuse of intravenous immunoglobulin
โœ Massoud Mahmoudi; Suzanne S. Teuber; M. Eric Gershwin ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Springer ๐ŸŒ English โš– 660 KB